RxDoctor Payments DataLook up a doctor →

MYRBETRIQ: payments to doctors

Payments that named MYRBETRIQ as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$6M
Providers
53,497
Transactions
267,394
Average per transaction
$22

The per-transaction average — $22 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 53,497 providers the average total is $112, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Astellas Pharma US Inc$5,677,41994.4%
Astellas Pharma Global Development$283,2664.7%
Astellas Pharma Inc$38,0070.6%
Astellas Pharma Europe BV$14,3930.2%
← All drugs & devices